Main Menu

Transformative Therapeutics

Our Cutting-Edge Assets

Our pipeline aims to disrupt existing treatment paradigm and features new molecular entities that inhibit novel targets with first–in–class potential for autoimmune, inflammatory, and other debilitating diseases.